跳至主要内容
临床试验/NCT01311479
NCT01311479Unknown不适用

Osteopathic Manipulation as a Therapeutic Intervention for Female Interstitial Cystitis Patients With Sacroiliac Joint Dysfunction

Pelvic and Sexual Health Institute2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2009年11月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
40
试验地点
2
主要终点
Improvement in Scores of Validated questionnaires pertaining to Interstitial Cystitis problems and symptoms

研究概览

简要总结

The proposed study will evaluate the effectiveness of Osteopathic manipulation of the sacro-iliac joint (SIJ) and the lumbar spine in symptomatic female interstitial cystitis (IC) patients with sacro-iliac joint dysfunction.

It is predicted that Osteopathic manipulation for a period of 12 weeks will result in subjective indices of increased comfort and objective indices of lower O'Leary-Sant Questionnaire, Pelvic Floor Impact Questionnaire (PIFQ-7), Female Sexual Function Index (FSFI) and SF-12 scores, lower visual analog scores for pain and urgency, decreased frequency on voiding diary and greater variation in resting/contraction perineometry scores.

详细描述

Patients will be evaluated and examined by an Osteopathic physician. This examination will consist of full osteopathic structural exam, and a focused examination of the sacroiliac joint and the surrounding musculature.

Subjects will then be treated based on the objective findings of the examination. Since the structural exam includes the whole body, other structural abnormalities will likely be identified and possible require treatment to aid in treatment of SIJD. Subjects will also be taught stretching routines in order to aid in treatment of the dysfunction.

Our control group will receive the same structural exam, and focused examination. Their treatment will involve massage, in an area not associated with the musculature of the SIJ. This will serve to identify a possible placebo effect, associated with simply providing a healing touch without focused treatment.

All of the subjects will be evaluated with standardized IC questionnaires at time of initial visit and subsequently re-evaluated with the same questionnaire in 4 week intervals. The patients will be followed for up to 6 months after treatment and evaluated at this time.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • At least 18 years of age
  • Patients who have osteopathic dysfunction
  • Patients with the Diagnosis of IC and Sacroiliac joint dysfunction
  • Patients currently stable on or off of a treatment regimen for IC for the past one month
  • Patients not currently undergoing physical therapy for pelvic floor dysfunction or SI joint dysfunction
  • Patients who have not used narcotics, skeletal muscle relaxants, or bladder instillations for the past month
  • Willingness to participate in the trial by signing an informed consent

排除标准

  • Pregnancy
  • Pelvic Masses
  • Patients with an Interstim neuromodulator implant
  • Patients requiring narcotics, bladder instillations, or skeletal muscle relaxants
  • History of vaginal or abdominal pelvic surgery within the last 3 months
  • Having a bladder over-distention within the last 1 month
  • Malignancy
  • Known spinal arthropathies
  • Hip replacements or other surgical stabilization
  • Herniated disks
  • Spinal stenosis

结局指标

主要结局

Improvement in Scores of Validated questionnaires pertaining to Interstitial Cystitis problems and symptoms

时间窗: Biweekly for three months

It is predicted that Osteopathic manipulation for a period of 12 weeks will result in subjective indices of increased comfort and objective indices of lower O'Leary-Sant Questionnaire, Pelvic Floor Impact Questionnaire (PIFQ-7), Female Sexual Function Index (FSFI) and SF-12 scores, lower visual analog scores for pain and urgency, decreased frequency on voiding diary and greater variation in resting/contraction perineometry scores.

次要结局

未报告次要终点

研究者

发起方
Pelvic and Sexual Health Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kristene Whitmore, M.D.

Medical Director

Pelvic and Sexual Health Institute

研究点 (2)

Loading locations...

相似试验